Preprint: cell type shapes how somatic variants alter gene expression in cancer
A preprint from Cold Spring Harbor Laboratory describes PrismSNV and Ligo-Seq, single-cell tools that reveal over 60% of candidate somatic SNVs produce cell-type-specific transcriptomic effects poorly predicted by sequence-based deleteriousness scores.
A preprint posted to bioRxiv on 2 November 2026 introduces PrismSNV and Ligo-Seq, a paired computational and experimental platform designed to measure the transcriptomic consequences of individual somatic single-nucleotide variants (SNVs) at single-cell resolution.
The authors applied their approach across 26 samples spanning three cancer types. They report that more than 60% of candidate SNVs showed statistically significant displacement in gene expression, but that the magnitude of that displacement varied by more than 30% depending on the cell type in which the variant was observed. Critically, established sequence-based deleteriousness metrics — tools commonly used to prioritise somatic variants in cancer genomics workflows — showed poor correlation with the measured cellular displacement, and fewer than 3% of the highest-displacing variants would have been ranked as top priorities by sequence annotation alone.
The findings suggest that cellular context is a major determinant of how a somatic variant manifests functionally, and that recurrence or sequence-based scoring alone may be insufficient to identify the variants with the greatest molecular impact. The work is relevant to researchers developing variant prioritisation frameworks for somatic cancer genomics and to those studying the functional consequences of private (non-recurrent) variants, which comprise the majority of the somatic mutation landscape in most tumour types.
This is a preprint and has not yet undergone peer review.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-11-02Cellular context shapes the transcriptomic impact of somatic variants